MedPath

Evaluation of nutrition, immunology and QOL of the patients with liver cirrhosis by administration of oral amino-acid agent and nutritional care

Phase 4
Conditions
iver Cirrhosis
Registration Number
JPRN-C000000398
Lead Sponsor
Gunma Liver Study Group (GLSG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

the patients with regularly administration of albumin, administration of other oral amino-acid agents, renal dysfunction, congenital amino-acid metabolic dysfunction, cirrhosis by autoimmune mechanism, scheduled treatment of varices within 3 months, with uncontrollable ascites

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cell immunity
Secondary Outcome Measures
NameTimeMethod
morbidity safety
© Copyright 2025. All Rights Reserved by MedPath